Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma
暂无分享,去创建一个
P. Merlet | L. Vercellino | C. Lebbé | M. Battistella | A. Sadoux | S. Mourah | L. Goldwirt | B. Louveau | B. Baroudjian | J. Delyon | K. Serror | F. Jouenne | C. Reger de Moura | F. Bouquet | Coralie Reger de Moura